doxazosin and tamsulosin

doxazosin has been researched along with tamsulosin in 98 studies

Research

Studies (98)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	13 (13.27)	18.2507
2000's	50 (51.02)	29.6817
2010's	29 (29.59)	24.3611
2020's	6 (6.12)	2.80

Authors

Authors	Studies
Ballard, S; Blagg, J; Fox, D; Kenny, B	1
Altenbach, RJ; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Condon, S; Drizin, I; Elmore, SW; Hancock, AA; Kerwin, JF; Meyer, MD; Sippy, KB; Tietje, K; Wendt, MD	1
Altenbach, RJ; Bai, H; Basha, FZ; Brune, ME; Buckner, SA; Carroll, WA; Drizin, I; Hancock, AA; Kerwin, JF; Lebold, SA; Lee, E; Meyer, MD; Pratt, JK; Sippy, KB; Tietje, K; Wendt, MD	1
Lombardo, F; Obach, RS; Waters, NJ	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Carter, AJ; Greengrass, PM; Kenny, BA; Naylor, AM; Read, AM; Wyllie, MG	1
Chapple, CR	2
Chalmers, DH; Kenny, BA; Miller, AM; Naylor, AM; O'Connell, J; Williamson, IJ	1
Fujimura, A; Harada, K; Ohmori, M	1
Brune, ME; Buckner, SA; Hancock, AA; Ireland, LM; Katwala, SP; Kerwin, JF; Milicic, I	1
Andersson, KE; Lepor, H; Wyllie, MG	1
Fernández Arjona, M; Fernández Borrell, A; Gómez Sancha, F; Mínguez Martínez, R; Peinado Ibarra, F; Pereira Sanz, I	1
Beduschi, MC; Beduschi, R; Oesterling, JE	2
Kim, SC; Lee, MY; Lim, SW; Seo, KK	1
Wyllie, MG	2
Clifford, GM; Farmer, RD	1
Benning, CM; Kyprianou, N	2
Benning, CM; Chon, J; Kyprianou, N	1
Caprino, L	1
Cotecchia, S; Goepel, M; Hein, P; Michel, MC	1
Dutkiewics, S	1
Bahnson, RR; Dull, P; Reagan, RW	1
Butler, WM; Galbreath, RW; Lief, JH; Merrick, GS; Wallner, KE	1
Keledjian, K; Kyprianou, N	1
Kirby, RS	1
Romics, I	1
Barqawi, A; Crawford, ED; Gamito, E; O'Donnell, C	1
Jensen, D; Kirby, RS; Mallen, S; Quinn, S	1
Doggrell, SA	1
Kyprianou, N; Rowland, RG; Tahmatzopoulos, A	1
Barnett, G; Brown, CT; Ellis, BW; Emberton, M; Ryan, M; Watson, V	1
Bedding, A; Emmick, JT; Jackson, G; Kloner, RA; Mitchell, MI; Pereira, A; Warner, MR	1
Mazo, EB; Shashin, MN	1
Combs, AJ; Donohoe, JM; Glassberg, KI	1
Desgrandchamps, F; Fitzpatrick, JM	1
Akbay, E; Bozlu, M; Cayan, S; Görür, S; Ulusoy, E	1
Muradian, AA	1
Basar, H; Basar, MM; Batislam, E; Ferhat, M; Tuglu, D; Yilmaz, E	1
Bae, JH; Jung, PB; Lee, JG	1
Athanasopoulos, A; Perimenis, P	1
Afshari, NA; Schwinn, DA	1
Irani, J	1
de la Rosette, JJ; Michel, MC; van Dijk, MM	1
de la Rosette, JJ; Michel, MC	1
O'Leary, MP	1
Bertero, E; Cairoli, CE; DA Ros, CT; Damião, R; Koff, WJ; Mesquita, F; Pinheiro, GE; Pompeo, AC; Rosenblatt, C; Wroclawski, ER	1
Cho, TW; Hong, YK; Jang, WK; Lee, YK; Lee, YT; Park, DS	1
Birowo, P; Djati, W; Rahardjo, D; Soebadi, DM; Sugandi, S; Wahyudi, I	1
Ding, Q; He, Z; Wang, J; Xu, K; Xue, Z; Zhang, Y	1
Herd, MK	1
Akova, YA; Altan-Yaycioglu, R; Ozkardes, H; Tufan, H; Yaycioglu, O	1
Awan, MA; Cheung, CM; Peh, KK; Sandramouli, S	1
Shaplygin, LV	1
Darstein, C; Guillaume, M; Jimenez, MC; Lonsdale, F; Mitchell, MI	1
Jin, J; Kong, CZ; Li, NC; Na, YQ; Qiu, SP; Song, YS; Sun, G; Sun, YC; Sun, YH; Wang, XF; Wu, SL; Ye, ZQ	1
Kitteringham, NR; Macdonald, I; Park, BK; Randle, LE; Sathish, JG; Williams, DP	1
Arikan, G; Bozkurt, O; Demir, O; Durak, I; Esen, A; Saatci, AO; Yaman, A	1
Mamalis, N	1
Andersson, KE	1
Bar-Yosef, Y; Kaver, I; Laufer, M; Mabjeesh, NJ; Matzkin, H; Neulander, EZ	1
Kaplon, DM; Nakada, SY; Sterrett, S	1
Adomat, H; Elterman, DS; Fleshner, N; Guns, E; Hersey, K; Lawrentschuk, N; Wood, CA	1
Chung, BH; Lee, SH; Mah, SY; Park, KK	1
Chatziralli, IP; Sergentanis, TN	1
Alan, C; Eren, AE; Ersay, AR; Ertung, Y; Kırılmaz, B; Koçoğlu, H	1
Krome, S	1
Dargallo, T; Gómez Veiras, JR; González, M; Molina Vázquez, ME; Pais, E; Palacios, MG; Somoza Arguibay, I; Tellado, M; Vela, D	1
Du, H; He, L; Ren, J; Wang, S	1
Jin, J; Wan, B; Wang, X; Yang, Y; Ye, H; Yu, W; Zhang, K; Zhang, N; Zhong, C	1
Casuccio, A; Cillino, G; Cillino, S; Pavone, C; Spitale, E	1
Fareed, K; Fouda, K; Gaafar, S; Marzouk, E; Yakoubi, R; Zahran, AR; Zaytoun, OM	1
Chung, BH; Chung, MS; Lee, SH; Park, KK; Yoo, SJ	1
Hill, TM; McEwen, C; Sherman, JJ; Welch, RW	1
Liu, Y; Mao, C; Qin, X; Yang, K; Yang, Z; Yuan, J	1
Al-Ahmar, B; Haridas, A; Hingorani, M; Syrimi, M	1
Araki, M; Araki, T; Monden, K	1
Borgia, JA; Gaynes, BI; Gaynes, JS; Micic, C	1
Carini, M; Corona, G; Ficarra, V; Gacci, M; Maggi, M; Novara, G; Sebastianelli, A; Serni, S; Shariat, SF; Zattoni, F	1
Fisher, E; Omar, MI; Subramonian, K	1
Graybill, SD; Vigersky, RA	1
Barkin, J; Berner, T; Diles, D; Franks, B	1
Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P	1
Anoopkumar-Dukie, S; Chess-Williams, R; Forbes, A; McDermott, C	1
Cao, Y; Chen, T; Guo, L; Niu, H; Wang, Y; Yang, X	1
Afsar Yildirim, M; Akdeniz, F; Bozkurt, O; Çelik, S; Demir, O; Gursoy Bulut, M; Hacihasanoglu, ML	1
Wang, XP	1
Bourdoumis, A; Buchholz, N; Dräger, D; Durner, L; Füllhase, C; Hakenberg, OW	1
Hori, Y; Ohyama, K; Sugiura, M	1
Dahm, P; Hwang, EC; Koziarz, A; Kuntz, GM; Oestreich, MC; Sathianathen, NJ; Scales, CD; Vernooij, RW	1
Liu, L; Narayanan, NS; Pottegård, A; Simmering, JE; Welsh, MJ	1
Athey, S; Bai, R; Bettegowda, C; Caffo, B; Carrero, JJ; Fischer, N; Huq, S; Khalafallah, AM; Kinzler, KW; Koenecke, A; Konig, MF; Mensh, BD; Nishimura, A; Papadopoulos, N; Powell, M; Shen, Z; Sparen, P; Staedtke, V; Stuart, EA; Thomas, DL; Trevisan, M; Vogelstein, B; Vogelstein, JT; Xiong, R; Zhou, S	1
Guo, J; Tang, R	1
Amorim, AC; Antunes, E; Britto-Júnior, J; Campos, R; da Silva-Filho, WP; De Nucci, G; Fregonesi, A; Monica, FZ; Moraes, MEA; Moraes, MO	1
Baldassarri, V; Cicione, A; D'Annunzio, S; DE Nunzio, C; Franco, A; Guarnotta, G; Lombardo, R; Mancini, E; Nacchia, A; Rovesti, LM; Tema, G; Tubaro, A; Voglino, OA	1

Reviews

29 review(s) available for doxazosin and tamsulosin

Article	Year
Pharmacological options in the treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 1997, Apr-25, Volume: 40, Issue:9 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Animals; Binding, Competitive; Controlled Clinical Trials as Topic; Endothelins; Enzyme Inhibitors; Humans; Male; Prostate; Prostatic Hyperplasia; Receptors, Adrenergic, alpha; Structure-Activity Relationship	1997
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016
Selective alpha 1-adrenoceptor antagonists in benign prostatic hyperplasia: rationale and clinical experience. European urology, 1996, Volume: 29, Issue:2 Topics: Adrenergic alpha-Antagonists; Blood Pressure; Clinical Trials as Topic; Doxazosin; Half-Life; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Vasodilation	1996
Prostatic alpha 1-adrenoceptors and uroselectivity. The Prostate, 1997, Feb-15, Volume: 30, Issue:3 Topics: Adrenergic alpha-Antagonists; Animals; Doxazosin; Humans; Male; Prazosin; Prostate; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1997
[Alpha blockers in the treatment of benign hyperplasia of the prostate]. Revista clinica espanola, 1997, Volume: 197, Issue:5 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoramin; Male; Phenoxybenzamine; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1997
Benign prostatic hyperplasia: use of drug therapy in primary care. Geriatrics, 1998, Volume: 53, Issue:3 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Primary Health Care; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Pharmacotherapy for benign prostatic hyperplasia--the potential for alpha 1-adrenoceptor subtype-specific blockade. British journal of urology, 1998, Volume: 81 Suppl 1 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Hormones; Humans; Male; Patient Selection; Plant Extracts; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	1998
Alpha-blockade therapy for benign prostatic hyperplasia: from a nonselective to a more selective alpha1A-adrenergic antagonist. Urology, 1998, Volume: 51, Issue:6 Topics: Adrenergic alpha-Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	1998
Medical therapy for benign prostatic hyperplasia: a review of the literature. European urology, 2000, Volume: 38, Issue:1 Topics: Adrenergic alpha-Antagonists; Doxazosin; Finasteride; Humans; Indoramin; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2000
[Drugs for the treatment of benign prostatic hypertrophy]. Minerva urologica e nefrologica = The Italian journal of urology and nephrology, 2000, Volume: 52, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Aged; Androgen Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Gonadotropin-Releasing Hormone; Humans; Leuprolide; Male; Middle Aged; Muscle, Smooth; Plant Extracts; Prazosin; Prostatic Hyperplasia; Receptors, Adrenergic, alpha-1; Serenoa; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urodynamics	2000
Managing benign prostatic hyperplasia. American family physician, 2002, Jul-01, Volume: 66, Issue:1 Topics: Complementary Therapies; Doxazosin; Humans; Male; Palpation; Prostatectomy; Prostatic Hyperplasia; Severity of Illness Index; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Urine	2002
[Pharmacologic treatment of benign prostatic hyperplasia]. Orvosi hetilap, 2003, Sep-14, Volume: 144, Issue:37 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2003
The role of alpha-blockers in the management of prostate cancer. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Angiogenesis Inhibitors; Anoikis; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Sulfonamides; Tamsulosin	2004
The clinical efficacy and tolerability of doxazosin standard and gastrointestinal therapeutic system for benign prostatic hyperplasia. BJU international, 2005, Volume: 95, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Clinical Trials as Topic; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2005
One drug fits all. BJU international, 2005, Volume: 96, Issue:4 Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Combinations; Drug Industry; Drug Therapy, Combination; Erectile Dysfunction; Humans; Hypertension; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2005
Efficacy of the combination of an alpha1-blocker with an anticholinergic agent in the treatment of lower urinary tract symptoms associated with bladder outlet obstruction. Expert opinion on pharmacotherapy, 2005, Volume: 6, Issue:14 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Benzhydryl Compounds; Benzilates; Cholinergic Antagonists; Cresols; Doxazosin; Drug Therapy, Combination; Humans; Male; Phenylpropanolamine; Prostatic Hyperplasia; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Tolterodine Tartrate; Urinary Bladder Neck Obstruction; Urinary Incontinence; Urodynamics; Urologic Diseases	2005
Effects of alpha(1)-adrenoceptor antagonists on male sexual function. Drugs, 2006, Volume: 66, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Aged; Doxazosin; Ejaculation; Erectile Dysfunction; Humans; Libido; Male; Middle Aged; Penile Erection; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2006
Treatment and pharmacologic management of BPH in the context of common comorbidities. The American journal of managed care, 2006, Volume: 12, Issue:5 Suppl Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Azasteroids; Cardiovascular Diseases; Comorbidity; Doxazosin; Drug Therapy, Combination; Dutasteride; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Global Health; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Transurethral Resection of Prostate; Treatment Outcome	2006
[Alpha blockers in use for symptomatic benign prostatic hyperplasia--are all drugs born equal?]. Harefuah, 2008, Volume: 147, Issue:6 Topics: Adrenergic alpha-Antagonists; Doxazosin; Evidence-Based Medicine; Humans; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2008
Risk factors for intraoperative floppy iris syndrome: a meta-analysis. Ophthalmology, 2011, Volume: 118, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Diabetes Complications; Doxazosin; Humans; Hypertension; Incidence; Intraoperative Complications; Iris; Iris Diseases; Odds Ratio; Phacoemulsification; Prazosin; Quinazolines; Risk Factors; Sulfonamides; Syndrome; Tamsulosin	2011
[How effective is finasteride?]. Deutsche medizinische Wochenschrift (1946), 2011, Volume: 136, Issue:8 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Drug Therapy, Combination; Finasteride; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin	2011
The efficacy and safety of alpha-1 blockers for benign prostatic hyperplasia: an overview of 15 systematic reviews. Current medical research and opinion, 2013, Volume: 29, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2013
Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. The journal of sexual medicine, 2014, Volume: 11, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Azasteroids; Doxazosin; Dutasteride; Ejaculation; Finasteride; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Sexual Dysfunction, Physiological; Sulfonamides; Tamsulosin; Urological Agents	2014
The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men. The Cochrane database of systematic reviews, 2014, Jun-10, Issue:6 Topics: Acute Disease; Adrenergic alpha-Antagonists; Adult; Device Removal; Doxazosin; Humans; Indoles; Male; Quinazolines; Randomized Controlled Trials as Topic; Recovery of Function; Sulfonamides; Tamsulosin; Urinary Catheterization; Urinary Retention; Urination	2014
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies. European urology, 2016, Volume: 69, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics	2016
[Therapeutic effects of α-adrenergic receptor antagonists on benign prostatic hyperplasia: A network meta-analysis]. Zhonghua nan ke xue = National journal of andrology, 2018, Volume: 24, Issue:3 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Indoles; Male; Network Meta-Analysis; Prostatic Hyperplasia; Quality of Life; Sexual Dysfunction, Physiological; Tamsulosin	2018
The Evidence Paradox of the Effectiveness between the Paediatric and Adult Stone-Forming Population: A Narrative Review. Urologia internationalis, 2019, Volume: 102, Issue:2 Topics: Adolescent; Adrenergic alpha-1 Receptor Antagonists; Age of Onset; Child; Doxazosin; Evidence-Based Medicine; Female; Humans; Male; Quinazolines; Remission Induction; Tamsulosin; Treatment Outcome; Urolithiasis; Urological Agents	2019
Alpha-blockers after shock wave lithotripsy for renal or ureteral stones in adults. The Cochrane database of systematic reviews, 2020, 11-12, Volume: 11 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Chemotherapy, Adjuvant; Combined Modality Therapy; Doxazosin; Humans; Indoles; Kidney Calculi; Lithotripsy; Middle Aged; Prazosin; Quinazolines; Randomized Controlled Trials as Topic; Tamsulosin; Ureteral Calculi	2020
Efficacy and tolerability of doxazosin gastro-intestinal therapeutic system versus tamsulosin in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: A systematic review and meta-analysis. Medicine, 2021, Aug-20, Volume: 100, Issue:33 Topics: Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Prostatic Hyperplasia; Tamsulosin; Treatment Outcome; Urological Agents	2021

Trials

20 trial(s) available for doxazosin and tamsulosin

Article	Year
Comparison of the antagonistic activity of tamsulosin and doxazosin at vascular alpha 1-adrenoceptors in humans. Naunyn-Schmiedeberg's archives of pharmacology, 1996, Volume: 354, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adult; Analysis of Variance; Cold Temperature; Cross-Over Studies; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Phenylephrine; Regional Blood Flow; Sulfonamides; Tamsulosin; Vasoconstriction	1996
alpha1-adrenoceptor selectivity: the North American experience. European urology, 1999, Volume: 36 Suppl 1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic Antagonists; Adult; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prostate; Single-Blind Method; Sulfonamides; Tamsulosin; Urethra	1999
Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy. Urology, 2002, Volume: 60, Issue:4 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Biopsy; Brachytherapy; Doxazosin; Follow-Up Studies; Humans; Iodine Radioisotopes; Male; Palladium; Postoperative Complications; Prazosin; Prostate; Prostate-Specific Antigen; Prostatic Neoplasms; Radioisotopes; Radiotherapy, Conformal; Sulfonamides; Tamsulosin; Treatment Outcome; Urinary Retention; Urination Disorders	2002
A randomized, double-blind crossover study of tamsulosin and controlled-release doxazosin in patients with benign prostatic hyperplasia. BJU international, 2003, Volume: 91, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2003
Doxazosin controlled release vs tamsulosin in the management of benign prostatic hyperplasia: an efficacy analysis. International journal of clinical practice, 2004, Volume: 58, Issue:1 Topics: Adrenergic alpha-Antagonists; Aged; Cross-Over Studies; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Humans; Male; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2004
Combination of finasteride and doxazosin for the treatment of benign prostatic hyperplasia. Expert opinion on pharmacotherapy, 2004, Volume: 5, Issue:5 Topics: Clinical Trials as Topic; Doxazosin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
Interaction between the phosphodiesterase 5 inhibitor, tadalafil and 2 alpha-blockers, doxazosin and tamsulosin in healthy normotensive men. The Journal of urology, 2004, Volume: 172, Issue:5 Pt 1 Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Adrenergic alpha-Antagonists; Aged; Carbolines; Cross-Over Studies; Cyclic Nucleotide Phosphodiesterases, Type 5; Double-Blind Method; Doxazosin; Drug Interactions; Hemodynamics; Humans; Male; Middle Aged; Phosphoric Diester Hydrolases; Sulfonamides; Tadalafil; Tamsulosin	2004
[Alfa-blockade with doxazosin vs tamsulozin in combination of intermittent androgen blockade in patients with prostate cancer]. Georgian medical news, 2005, Issue:120 Topics: Adrenergic alpha-Antagonists; Aged; Androgen Antagonists; Antineoplastic Agents; Doxazosin; Drug Therapy, Combination; Flutamide; Humans; Male; Middle Aged; Prostatic Neoplasms; Sulfonamides; Tamsulosin; Urodynamics	2005
The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. The Journal of urology, 2005, Volume: 173, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Doxazosin; Female; Humans; Male; Middle Aged; Pain Measurement; Prazosin; Sulfonamides; Tamsulosin; Treatment Outcome; Ureteral Calculi	2005
A randomised, double-blind study comparing the efficacy and tolerability of controlled-release doxazosin and tamsulosin in the treatment of benign prostatic hyperplasia in Brazil. International journal of clinical practice, 2006, Volume: 60, Issue:10 Topics: Adrenergic alpha-Antagonists; Aged; Delayed-Action Preparations; Double-Blind Method; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Treatment Outcome	2006
Evaluation of short term clinical effects and presumptive mechanism of botulinum toxin type A as a treatment modality of benign prostatic hyperplasia. Yonsei medical journal, 2006, Oct-31, Volume: 47, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Botulinum Toxins, Type A; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Neuromuscular Agents; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2006
Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia. International journal of urology : official journal of the Japanese Urological Association, 2006, Volume: 13, Issue:11 Topics: Adrenergic alpha-Antagonists; Aged; Blood Pressure; Doxazosin; Heart Rate; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome; Urethral Diseases; Urinary Bladder Neck Obstruction; Urodynamics	2006
Doxazosin gastrointestinal therapeutic system versus tamsulosin for the treatment of benign prostatic hyperplasia: a study in Chinese patients. International journal of urology : official journal of the Japanese Urological Association, 2007, Volume: 14, Issue:2 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; China; Delayed-Action Preparations; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2007
Hemodynamic interaction between a daily dosed phosphodiesterase 5 inhibitor, tadalafil, and the alpha-adrenergic blockers, doxazosin and tamsulosin, in middle-aged healthy male subjects. Journal of clinical pharmacology, 2007, Volume: 47, Issue:10 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Blood Pressure; Carbolines; Cross-Over Studies; Double-Blind Method; Doxazosin; Drug Interactions; Drug Therapy, Combination; Heart Rate; Hemodynamics; Humans; Male; Middle Aged; Phosphodiesterase Inhibitors; Sulfonamides; Tadalafil; Tamsulosin	2007
[Comparison of different drugs on the treatment of benign prostate hyperplasia]. Zhonghua wai ke za zhi [Chinese journal of surgery], 2007, Jul-15, Volume: 45, Issue:14 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Androstadienes; Double-Blind Method; Doxazosin; Enzyme Inhibitors; Finasteride; Follow-Up Studies; Humans; Male; Middle Aged; Naphthalenes; Piperazines; Plant Extracts; Prazosin; Prostate; Prostatic Hyperplasia; Quality of Life; Secale; Sulfonamides; Tamsulosin; Treatment Outcome	2007
Effect of doxazosin gastrointestinal therapeutic system 4 mg vs tamsulosin 0.2 mg on nocturia in Chinese men with lower urinary tract symptoms: a prospective, multicenter, randomized, open, parallel study. Urology, 2011, Volume: 78, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Nocturia; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urination Disorders	2011
Tamsulosin and doxazosin as adjunctive therapy following shock-wave lithotripsy of renal calculi: randomized controlled trial. Urological research, 2012, Volume: 40, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Combined Modality Therapy; Doxazosin; Female; Humans; Kidney Calculi; Lithotripsy; Male; Middle Aged; Prospective Studies; Sulfonamides; Tamsulosin	2012
Comparative rapid onset of efficacy between doxazosin gastrointestinal therapeutic system and tamsulosin in patients with lower urinary tract symptoms from benign prostatic hyperplasia: a multicentre, prospective, randomised study. International journal of clinical practice, 2011, Volume: 65, Issue:11 Topics: Adrenergic alpha-1 Receptor Antagonists; Doxazosin; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2011
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study. Acta medica Okayama, 2013, Volume: 67, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome	2013
A Randomized, Open-Label, Comparative Study of Efficacy and Safety of Tolterodine Combined with Tamsulosin or Doxazosin in Patients with Benign Prostatic Hyperplasia. Medical science monitor : international medical journal of experimental and clinical research, 2016, Jun-04, Volume: 22 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Humans; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2016

Other Studies

49 other study(ies) available for doxazosin and tamsulosin

Article	Year
Structure-activity studies for a novel series of tricyclic substituted hexahydrobenz[e]isoindole alpha(1A) adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia (BPH). Journal of medicinal chemistry, 2000, Apr-20, Volume: 43, Issue:8 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Cell Line; Dogs; Heterocyclic Compounds, 3-Ring; Indoles; Male; Pressure; Prostatic Hyperplasia; Radioligand Assay; Rats; Rats, Inbred SHR; Stereoisomerism; Structure-Activity Relationship; Urethra	2000
Structure-activity studies for a novel series of bicyclic substituted hexahydrobenz[e]isoindole alpha1A adrenoceptor antagonists as potential agents for the symptomatic treatment of benign prostatic hyperplasia. Journal of medicinal chemistry, 2001, Jun-07, Volume: 44, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Dogs; Doxazosin; Drug Design; Humans; Indicators and Reagents; Indoles; Isoindoles; L Cells; Male; Mice; Models, Molecular; Molecular Conformation; Prazosin; Prostate; Prostatic Hyperplasia; Quinazolines; Radioligand Assay; Rats; Receptors, Adrenergic, alpha-1; Recombinant Proteins; Spleen; Structure-Activity Relationship; Vas Deferens	2001
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Effect of alpha 1 adrenoceptor antagonists on prostatic pressure and blood pressure in the anesthetized dog. Urology, 1994, Volume: 44, Issue:1 Topics: Adrenergic alpha-Antagonists; Affinity Labels; Anesthesia, Endotracheal; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Male; Models, Biological; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin	1994
Evaluation of the pharmacological selectivity profile of alpha 1 adrenoceptor antagonists at prostatic alpha 1 adrenoceptors: binding, functional and in vivo studies. British journal of pharmacology, 1996, Volume: 118, Issue:4 Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Aorta, Thoracic; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Doxazosin; Humans; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Norepinephrine; Phenylephrine; Prazosin; Pressure; Prostate; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	1996
Effects of selective and nonselective alpha-1-adrenoceptor antagonists on intraurethral and arterial pressures in intact conscious dogs. Pharmacology, 1996, Volume: 53, Issue:6 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Doxazosin; Male; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Time Factors; Urethra	1996
Comparison of relaxation responses of cavernous and trigonal smooth muscles from rabbits by alpha1-adrenoceptor antagonists; prazosin, terazosin, doxazosin, and tamsulosin. Journal of Korean medical science, 1999, Volume: 14, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; In Vitro Techniques; Muscle Contraction; Muscle Relaxation; Muscle, Smooth; Prazosin; Rabbits; Sulfonamides; Tamsulosin	1999
Suppression of human prostate cancer cell growth by alpha1-adrenoceptor antagonists doxazosin and terazosin via induction of apoptosis. Cancer research, 2000, Aug-15, Volume: 60, Issue:16 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Antineoplastic Agents; Apoptosis; Cell Division; Cells, Cultured; Doxazosin; Growth Inhibitors; Humans; Male; Mice; Mice, SCID; Muscle, Smooth; Neoplasm Transplantation; Prazosin; Prostate; Prostatic Neoplasms; Receptors, Adrenergic, alpha-1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Sulfonamides; Tamsulosin; Transplantation, Heterologous	2000
Effects of alpha(1)-adrenoceptor (alpha(1)-AR) antagonists on cell proliferation and apoptosis in the prostate: therapeutic implications in prostatic disease. The Prostate. Supplement, 2000, Volume: 9 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Biopsy; Cell Division; Doxazosin; Humans; Male; Muscle, Smooth; Prazosin; Prostate; Prostatic Diseases; Prostatic Hyperplasia; Prostatic Neoplasms; Stromal Cells; Sulfonamides; Tamsulosin	2000
A quantitative analysis of antagonism and inverse agonism at wild-type and constitutively active hamster alpha1B-adrenoceptors. Naunyn-Schmiedeberg's archives of pharmacology, 2001, Volume: 363, Issue:1 Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Cell Line; Chromones; Cricetinae; Dose-Response Relationship, Drug; Doxazosin; Fibroblasts; Inositol Phosphates; Phenethylamines; Prazosin; Quinazolines; Rats; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tetralones; Tritium	2001
Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia. International urology and nephrology, 2001, Volume: 32, Issue:3 Topics: Adrenergic alpha-Antagonists; Aged; Doxazosin; Enzyme Inhibitors; Finasteride; Humans; Male; Middle Aged; Phytotherapy; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2001
Quinazoline-derived alpha1-adrenoceptor antagonists induce prostate cancer cell apoptosis via an alpha1-adrenoceptor-independent action. Cancer research, 2002, Jan-15, Volume: 62, Issue:2 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Apoptosis; Dose-Response Relationship, Drug; Doxazosin; Humans; Male; Prazosin; Prostatic Neoplasms; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Tumor Cells, Cultured	2002
Anoikis induction by quinazoline based alpha 1-adrenoceptor antagonists in prostate cancer cells: antagonistic effect of bcl-2. The Journal of urology, 2003, Volume: 169, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Anoikis; Cell Adhesion; Cell Survival; Doxazosin; Endothelial Growth Factors; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Intercellular Signaling Peptides and Proteins; Lymphokines; Male; Neoplasm Invasiveness; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Sulfonamides; Tamsulosin; Transcription Factors; Tumor Cells, Cultured; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors	2003
Herbal and vitamin supplement use in a prostate cancer screening population. Urology, 2004, Volume: 63, Issue:2 Topics: Adenocarcinoma; Adrenergic alpha-Antagonists; Adult; Aged; Colorado; Complementary Therapies; Dietary Supplements; Doxazosin; Drug Utilization; Family; Finasteride; Health Surveys; Humans; Male; Mass Screening; Middle Aged; Penile Erection; Phytotherapy; Plant Preparations; Prazosin; Prostatic Hyperplasia; Prostatic Neoplasms; Self Medication; Socioeconomic Factors; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders; Vitamins	2004
Eliciting preferences for drug treatment of lower urinary tract symptoms associated with benign prostatic hyperplasia. The Journal of urology, 2004, Volume: 172, Issue:6 Pt 1 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Azasteroids; Doxazosin; Dutasteride; Humans; Male; Middle Aged; Patient Satisfaction; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination Disorders	2004
[Use of alpha-adrenoblockers in therapy of benign prostatic hyperplasia in patients with arterial hypertension]. Terapevticheskii arkhiv, 2004, Volume: 76, Issue:10 Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Antineoplastic Agents; Doxazosin; Humans; Hypertension; Male; Middle Aged; Prostatic Hyperplasia; Sulfonamides; Tamsulosin	2004
Primary bladder neck dysfunction in children and adolescents II: results of treatment with alpha-adrenergic antagonists. The Journal of urology, 2005, Volume: 173, Issue:1 Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Child; Child, Preschool; Doxazosin; Electromyography; Female; Humans; Male; Sulfonamides; Tamsulosin; Urinary Bladder Neck Obstruction; Urination Disorders; Urodynamics	2005
A comparison of four different alpha1-blockers in benign prostatic hyperplasia patients with and without diabetes. Scandinavian journal of urology and nephrology, 2004, Volume: 38, Issue:5 Topics: Adrenergic alpha-Antagonists; Aged; Aged, 80 and over; Cohort Studies; Diabetes Mellitus; Doxazosin; Follow-Up Studies; Humans; Male; Middle Aged; Prazosin; Probability; Prostatic Hyperplasia; Quinazolines; Reference Values; Retrospective Studies; Risk Assessment; Severity of Illness Index; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2004
The effects of alpha-adrenoceptor antagonists on the urethral perfusion pressure of the female rat. BJU international, 2005, Volume: 96, Issue:7 Topics: Adrenergic alpha-Antagonists; Animals; Blood Pressure; Doxazosin; Female; Male; Muscle Contraction; Muscle, Smooth; Phentolamine; Pressure; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin; Urethra; Urinary Bladder Neck Obstruction	2005
Alpha1-adrenergic antagonists and floppy iris syndrome: tip of the iceberg? Ophthalmology, 2005, Volume: 112, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Phacoemulsification; Prazosin; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2005
Are all alpha-blockers created the same? European urology, 2006, Volume: 49, Issue:3 Topics: Adrenergic alpha-Antagonists; Adult; Clinical Trials as Topic; Dizziness; Doxazosin; Humans; Male; Middle Aged; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin	2006
alpha-blocker treatment of urolithiasis. European urology, 2006, Volume: 50, Issue:2 Topics: Adrenergic alpha-Antagonists; Doxazosin; Drug Therapy, Combination; Glucocorticoids; Humans; Prazosin; Sulfonamides; Tamsulosin; Urolithiasis	2006
Intraoperative floppy-iris syndrome with doxazosin. Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Prospective Studies; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin	2007
The effects of systemic alpha-1 adrenergic antagonists on pupil diameter in rats. Current eye research, 2007, Volume: 32, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Doxazosin; Iris; Male; Prazosin; Pupil; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin	2007
Incidence of intraoperative floppy iris syndrome in patients on either systemic or topical alpha1-adrenoceptor antagonist. American journal of ophthalmology, 2007, Volume: 143, Issue:6 Topics: Administration, Topical; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Cataract Extraction; Doxazosin; Female; Humans; Hypertension; Incidence; Intraoperative Complications; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2007
[Using of alpha1-adrenoreceptor blockers in urologic practice]. Voenno-meditsinskii zhurnal, 2007, Volume: 328, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Aged; Doxazosin; Humans; Middle Aged; Sulfonamides; Tamsulosin; Treatment Outcome; Urination Disorders; Urodynamics	2007
alpha(1)-Adrenoceptor antagonists prevent paracetamol-induced hepatotoxicity in mice. British journal of pharmacology, 2008, Volume: 153, Issue:4 Topics: Acetaminophen; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Catecholamines; Chemical and Drug Induced Liver Injury; Disease Models, Animal; Doxazosin; Erythrocytes; Gene Expression Regulation, Enzymologic; Glutamate-Cysteine Ligase; Glutathione; Heme Oxygenase-1; Liver; Liver Circulation; Liver Diseases; Male; Membrane Proteins; Mice; Prazosin; Protein Binding; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Time Factors; Transaminases	2008
The effect of various alpha1-adrenergic receptor antagonists on pupillary dilation. Annals of ophthalmology (Skokie, Ill.), 2008,Spring, Volume: 40, Issue:1 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Doxazosin; Humans; Iris Diseases; Male; Middle Aged; Prospective Studies; Prostatic Hyperplasia; Pupil; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
Intraoperative floppy-iris syndrome associated with systemic alpha blockers. Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:7 Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cataract Extraction; Doxazosin; Humans; Intraoperative Complications; Iris Diseases; Male; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Syndrome; Tamsulosin	2008
How many drugs for LUTS due to BPH are too many? The Journal of urology, 2008, Volume: 180, Issue:3 Topics: Adrenergic alpha-Antagonists; Benzhydryl Compounds; Cresols; Doxazosin; Drug Therapy, Combination; Enzyme Inhibitors; Erectile Dysfunction; Finasteride; Humans; Imidazoles; Male; Muscarinic Antagonists; Phenylpropanolamine; Piperazines; Prostatic Hyperplasia; Sulfonamides; Sulfones; Tamsulosin; Tolterodine Tartrate; Triazines; Urination Disorders; Vardenafil Dihydrochloride	2008
Medical management of acute urolithiasis in one American academic emergency room. BJU international, 2010, Volume: 105, Issue:6 Topics: Adolescent; Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Child; Doxazosin; Emergency Service, Hospital; Female; Humans; Male; Middle Aged; Retrospective Studies; Sulfonamides; Tamsulosin; Treatment Outcome; Urolithiasis; Young Adult	2010
Investigating contamination of phytotherapy products for benign prostatic hyperplasia with alpha-blockers and 5alpha-reductase inhibitors. The Journal of urology, 2010, Volume: 183, Issue:5 Topics: Administration, Oral; Adrenergic alpha-Antagonists; Azasteroids; Capsules; Cholestenone 5 alpha-Reductase; Chromatography, High Pressure Liquid; Doxazosin; Drug Contamination; Dutasteride; Enzyme Inhibitors; Finasteride; Humans; Male; Phytotherapy; Prazosin; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tablets; Tamsulosin	2010
Effects of α-blocker 'add on' treatment on blood pressure in symptomatic BPH with or without concomitant hypertension. Prostate cancer and prostatic diseases, 2010, Volume: 13, Issue:4 Topics: Adrenergic alpha-Antagonists; Aged; Antihypertensive Agents; Blood Pressure; Doxazosin; Drug Combinations; Humans; Hypertension; Male; Middle Aged; Models, Biological; Polypharmacy; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2010
Comparison of effects of alpha receptor blockers on endothelial functions and coagulation parameters in patients with benign prostatic hyperplasia. Urology, 2011, Volume: 77, Issue:6 Topics: Adrenergic alpha-Antagonists; Aged; Blood Coagulation; Blood Pressure; Brachial Artery; Doxazosin; Endothelial Cells; Endothelium, Vascular; Humans; Male; Middle Aged; Prazosin; Prostate-Specific Antigen; Prostatic Hyperplasia; Quinazolines; Sulfonamides; Tamsulosin; Ultrasonography	2011
[Role of alpha antagonists in uncoordinated micturition syndrome in childhood]. Cirugia pediatrica : organo oficial de la Sociedad Espanola de Cirugia Pediatrica, 2010, Volume: 23, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Child; Child, Preschool; Doxazosin; Female; Humans; Male; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; Urination Disorders	2010
Cell membrane chromatography competitive binding analysis for characterization of α1A adrenoreceptor binding interactions. Analytical and bioanalytical chemistry, 2011, Volume: 400, Issue:10 Topics: Adrenergic alpha-1 Receptor Antagonists; Binding, Competitive; Cell Line; Cell Membrane; Chromatography; Doxazosin; Humans; Methods; Phentolamine; Piperazines; Prazosin; Protein Binding; Quinazolines; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin	2011
Pharmacologic pupil dilation as a predictive test for the risk for intraoperative floppy-iris syndrome. Journal of cataract and refractive surgery, 2011, Volume: 37, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Cohort Studies; Doxazosin; Drug Combinations; Humans; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prazosin; Predictive Value of Tests; Prospective Studies; Pupil; Risk Factors; Sensitivity and Specificity; Sulfonamides; Syndrome; Tamsulosin; Tropicamide	2011
Prescriber monitoring for benign prostatic hyperplasia within a family medicine clinic: a comparison of medication classes. Journal of pharmacy practice, 2012, Volume: 25, Issue:2 Topics: 5-alpha Reductase Inhibitors; Adrenergic alpha-Antagonists; Aged; Doxazosin; Drug Therapy, Combination; Family Practice; Humans; Indoles; Male; Middle Aged; Practice Patterns, Physicians'; Prazosin; Prostatic Hyperplasia; Quinazolines; Retrospective Studies; Sulfonamides; Tamsulosin	2012
Intraoperative floppy iris syndrome (IFIS) in patients receiving tamsulosin or doxazosin-a UK-based comparison of incidence and complication rates. Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie, 2013, Volume: 251, Issue:6 Topics: Adrenergic alpha-1 Receptor Antagonists; Atropine; Doxazosin; Drug Therapy, Combination; Female; Humans; Incidence; Intraoperative Complications; Iris Diseases; Male; Muscle, Smooth; Mydriatics; Phacoemulsification; Phenylephrine; Prostatic Hyperplasia; Pupil; Retrospective Studies; Sulfonamides; Syndrome; Tamsulosin; United Kingdom	2013
Quantitation of in vitro α-1 adrenergic receptor antagonist binding capacity to biologic melanin using tandem mass spectrometry. Current eye research, 2013, Volume: 38, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Biological Assay; Cattle; Chloroquine; Choroid; Doxazosin; In Vitro Techniques; Iris; Melanins; Protein Binding; Retinal Pigment Epithelium; Sulfonamides; Tamsulosin; Tandem Mass Spectrometry	2013
Effects of α-blocker therapy on active duty military and military retirees for benign prostatic hypertrophy on diabetic complications. Military medicine, 2015, Volume: 180, Issue:3 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Diabetes Complications; Diabetes Mellitus, Type 2; Doxazosin; Humans; Male; Middle Aged; Military Personnel; Prostatic Hyperplasia; Retirement; Retrospective Studies; Sulfonamides; Tamsulosin; United States	2015
Alpha blocker monotherapy versus combination therapy with antimuscarinics in men with persistent LUTS refractory to alpha-adrenergic treatment: patterns of persistence. The Canadian journal of urology, 2015, Volume: 22, Issue:4 Topics: Administrative Claims, Healthcare; Adrenergic alpha-Antagonists; Aged; Benzofurans; Doxazosin; Drug Therapy, Combination; Humans; Longitudinal Studies; Male; Mandelic Acids; Medication Adherence; Middle Aged; Muscarinic Antagonists; Ontario; Prazosin; Prostatic Hyperplasia; Prostatism; Pyrrolidines; Quinazolines; Retrospective Studies; Solifenacin Succinate; Sulfonamides; Tamsulosin; Tolterodine Tartrate	2015
Relative cytotoxic potencies and cell death mechanisms of α1 -adrenoceptor antagonists in prostate cancer cell lines. The Prostate, 2016, Volume: 76, Issue:8 Topics: Adrenergic alpha-1 Receptor Antagonists; Antineoplastic Agents; Apoptosis; Autophagy; Cell Death; Cell Line, Tumor; Cell Survival; Doxazosin; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indoles; Male; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Prazosin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Sulfonamides; Tamsulosin	2016
Tadalafil versus alpha blockers (alfuzosin, doxazosin, tamsulosin and silodosin) as medical expulsive therapy for < 10 mm distal and proximal ureteral stones. Archivio italiano di urologia, andrologia : organo ufficiale [di] Societa italiana di ecografia urologica e nefrologica, 2018, Jun-30, Volume: 90, Issue:2 Topics: Adrenergic alpha-Antagonists; Adult; Aged; Aged, 80 and over; Doxazosin; Female; Flank Pain; Humans; Indoles; Male; Middle Aged; Quinazolines; Retrospective Studies; Tadalafil; Tamsulosin; Tomography, X-Ray Computed; Treatment Outcome; Ureteral Calculi; Urological Agents; Young Adult	2018
Evaluation of syncope association with α Die Pharmazie, 2019, 12-01, Volume: 74, Issue:12 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Doxazosin; Humans; Hypertension; Indoles; Male; Middle Aged; Prazosin; Prostatic Hyperplasia; Quinazolines; Syncope; Tamsulosin	2019
Association of Glycolysis-Enhancing α-1 Blockers With Risk of Developing Parkinson Disease. JAMA neurology, 2021, 04-01, Volume: 78, Issue:4 Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cohort Studies; Databases, Factual; Denmark; Doxazosin; Female; Follow-Up Studies; Glycolysis; Humans; Male; Middle Aged; Parkinson Disease; Prazosin; Quinazolines; Registries; Risk Factors; Tamsulosin; United States	2021
Alpha-1 adrenergic receptor antagonists to prevent hyperinflammation and death from lower respiratory tract infection. eLife, 2021, 06-11, Volume: 10 Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Doxazosin; Humans; Male; Middle Aged; Pneumonia, Viral; Respiration, Artificial; Respiratory Distress Syndrome; Retrospective Studies; Sweden; Tamsulosin; United States	2021
6-nitrodopamine is a major endogenous modulator of human vas deferens contractility. Andrology, 2022, Volume: 10, Issue:8 Topics: Adrenergic Antagonists; Amitriptyline; Animals; Antidepressive Agents, Tricyclic; Carbamazepine; Chromatography, Liquid; Desipramine; Dopamine; Doxazosin; Epinephrine; Humans; Male; Muscle Contraction; Muscle, Smooth; NG-Nitroarginine Methyl Ester; Nitric Oxide; Norepinephrine; Prazosin; Rats; Receptors, Adrenergic; Tamsulosin; Tandem Mass Spectrometry; Vas Deferens	2022
Adverse events related to alpha-blockers: analysis of real-life data from Eudra-Vigilance. Minerva urology and nephrology, 2023, Volume: 75, Issue:4 Topics: Adrenergic alpha-Antagonists; Doxazosin; Humans; Hypotension, Orthostatic; Prazosin; Tamsulosin; Urogenital Diseases	2023